RNA-GESTEUERTES ENGINEERING EINES MENSCHLICHEN GENOMS

European patent · EP3553174 · In force

Register entry

Publication number
EP3553174
Application number
EP19173061
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 16, 2013
Published
Oct 16, 2019
Granted
Apr 30, 2025
Protection ends at the latest
Dec 15, 2033
Next annual fee due
Dec 31, 2026
IPC classes
C12N 15/00 (2006.01)
C12N 9/22 (2006.01)
C12N 15/10 (2006.01)
C12N 15/90 (2006.01)
Priority
US 201261738355 P 17.12.2012
US 201361779169 P 13.03.2013
Divided from
EP13863815
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 11, 2026

    Change

    Published in Swissreg on 11.02.2026

  2. Feb 11, 2026

    Change

    Published in Swissreg on 11.02.2026

  3. Jan 14, 2026

    Change

    Published in Swissreg on 14.01.2026

  4. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  5. Aug 4, 2025

    Agent entered

    Representative
    Bovard SA, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 04.08.2025

  6. Apr 30, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 30.04.2025

Parties

Holder

President and Fellows of Harvard College

17 Quincy Street, Cambridge, MA 02138, US

Agent

Bovard AG

Bovard SA

Optingenstrasse 16, 3013 Bern

Inventor

CHURCH, George M.

Brookline, MA 02446, US

MALI, Prashant

Somerville, MA 02143, US

YANG, Luhan

Brookline, MA 02446, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.